BACKGROUND: Studies in persons without HIV infection have compared percentage body fat (%BF) and waist circumference as markers of risk for the complications of excess adiposity, but only limited study has been conducted in HIV-infected subjects. OBJECTIVE: We compared anthropometric and magnetic resonance imaging (MRI)-based adiposity measures as correlates of metabolic complications of adiposity in HIV-infected and control subjects. DESIGN: The study was a cross-sectional analysis of 666 HIV-positive and 242 control subjects in the Fat Redistribution and Metabolic Change in HIV Infection (FRAM) study assessing body mass index (BMI), waist (WC) and hip (HC) circumferences, waist-to-hip ratio (WHR), %BF, and MRI-measured regional adipose tissue. Study outcomes were 3 metabolic risk variables [homeostatic model assessment (HOMA), triglycerides, and HDL cholesterol]. Analyses were stratified by sex and HIV status and adjusted for demographic, lifestyle, and HIV-related factors. RESULTS: In HIV-infected and control subjects, univariate associations with HOMA, triglycerides, and HDL were strongest for WC, MRI-measured visceral adipose tissue, and WHR; in all cases, differences in correlation between the strongest measures for each outcome were small (r <or= 0.07). Multivariate adjustment found no significant difference for optimally fitting models between the use of anthropometric and MRI measures, and the magnitudes of differences were small (adjusted R(2) <or= 0.06). For HOMA and HDL, WC appeared to be the best anthropometric correlate of metabolic complications, whereas, for triglycerides, the best was WHR. CONCLUSION: Relations of simple anthropometric measures with HOMA, triglycerides, and HDL cholesterol are approximately as strong as MRI-measured whole-body adipose tissue depots in both HIV-infected and control subjects.
BACKGROUND: Studies in persons without HIV infection have compared percentage body fat (%BF) and waist circumference as markers of risk for the complications of excess adiposity, but only limited study has been conducted in HIV-infected subjects. OBJECTIVE: We compared anthropometric and magnetic resonance imaging (MRI)-based adiposity measures as correlates of metabolic complications of adiposity in HIV-infected and control subjects. DESIGN: The study was a cross-sectional analysis of 666 HIV-positive and 242 control subjects in the Fat Redistribution and Metabolic Change in HIV Infection (FRAM) study assessing body mass index (BMI), waist (WC) and hip (HC) circumferences, waist-to-hip ratio (WHR), %BF, and MRI-measured regional adipose tissue. Study outcomes were 3 metabolic risk variables [homeostatic model assessment (HOMA), triglycerides, and HDL cholesterol]. Analyses were stratified by sex and HIV status and adjusted for demographic, lifestyle, and HIV-related factors. RESULTS: In HIV-infected and control subjects, univariate associations with HOMA, triglycerides, and HDL were strongest for WC, MRI-measured visceral adipose tissue, and WHR; in all cases, differences in correlation between the strongest measures for each outcome were small (r <or= 0.07). Multivariate adjustment found no significant difference for optimally fitting models between the use of anthropometric and MRI measures, and the magnitudes of differences were small (adjusted R(2) <or= 0.06). For HOMA and HDL, WC appeared to be the best anthropometric correlate of metabolic complications, whereas, for triglycerides, the best was WHR. CONCLUSION: Relations of simple anthropometric measures with HOMA, triglycerides, and HDL cholesterol are approximately as strong as MRI-measured whole-body adipose tissue depots in both HIV-infected and control subjects.
Authors: Nadine R Sahyoun; Amy L Anderson; Alka M Kanaya; Pauline Koh-Banerjee; Stephen B Kritchevsky; Nathalie de Rekeneire; Frances A Tylavsky; Ann V Schwartz; Jung Sun Lee; Tamara B Harris Journal: Am J Clin Nutr Date: 2005-09 Impact factor: 7.045
Authors: Peter Bacchetti; Barbara Gripshover; Carl Grunfeld; Steven Heymsfield; Heather McCreath; Dennis Osmond; Michael Saag; Rebecca Scherzer; Michael Shlipak; Phyllis Tien Journal: J Acquir Immune Defic Syndr Date: 2005-10-01 Impact factor: 3.731
Authors: W M El-Sadr; C M Mullin; A Carr; C Gibert; C Rappoport; F Visnegarwala; C Grunfeld; S S Raghavan Journal: HIV Med Date: 2005-03 Impact factor: 3.180
Authors: Sara E Dolan; Colleen Hadigan; Kathleen M Killilea; Meghan P Sullivan; Linda Hemphill; Robert S Lees; David Schoenfeld; Steven Grinspoon Journal: J Acquir Immune Defic Syndr Date: 2005-05-01 Impact factor: 3.731
Authors: Wei Shen; Mark Punyanitya; Jun Chen; Dympna Gallagher; Jeanine Albu; Xavier Pi-Sunyer; Cora E Lewis; Carl Grunfeld; Stanley Heshka; Steven B Heymsfield Journal: Obesity (Silver Spring) Date: 2006-04 Impact factor: 5.002
Authors: Barbara J Nicklas; Brenda W J H Penninx; Matteo Cesari; Stephen B Kritchevsky; Anne B Newman; Alka M Kanaya; Marco Pahor; Ding Jingzhong; Tamara B Harris Journal: Am J Epidemiol Date: 2004-10-15 Impact factor: 4.897
Authors: Phyllis C Tien; Constance Benson; Andrew R Zolopa; Stephen Sidney; Dennis Osmond; Carl Grunfeld Journal: Am J Epidemiol Date: 2006-03-08 Impact factor: 4.897
Authors: G D Friedman; G R Cutter; R P Donahue; G H Hughes; S B Hulley; D R Jacobs; K Liu; P J Savage Journal: J Clin Epidemiol Date: 1988 Impact factor: 6.437
Authors: Eugene Mutimura; Kathryn Anastos; Mardge Cohen; Agnes Binagwaho; Donald P Kotler Journal: J Int Assoc Physicians AIDS Care (Chic) Date: 2010 May-Jun
Authors: M B Schulze; B Thorand; A Fritsche; H U Häring; F Schick; A Zierer; W Rathmann; J Kröger; A Peters; H Boeing; N Stefan Journal: Diabetologia Date: 2012-02-17 Impact factor: 10.122
Authors: Deborah A Levine; David A Calhoun; Ronald J Prineas; Mary Cushman; Virginia J Howard; George Howard Journal: Am J Hypertens Date: 2011-01-13 Impact factor: 2.689
Authors: John Y Rhee; Tumi Divine Bahtila; Dennis Palmer; Pius Muffih Tih; Judith A Aberg; Derek LeRoith; Jennifer Jao Journal: Diabetes Metab Res Rev Date: 2016-04-06 Impact factor: 4.876
Authors: Livio Azzoni; Nigel J Crowther; Cynthia Firnhaber; Andrea S Foulkes; Xiangfan Yin; Deborah Glencross; Robert Gross; Mitch D Kaplan; Emmanouil Papasavvas; Doreen Schulze; Wendy Stevens; Tessa van der Merwe; Rita Waisberg; Ian Sanne; Luis J Montaner Journal: J Int AIDS Soc Date: 2010-09-07 Impact factor: 5.396
Authors: Stacy A Porter; Joseph M Massaro; Udo Hoffmann; Ramachandran S Vasan; Christopher J O'Donnel; Caroline S Fox Journal: Diabetes Care Date: 2009-02-24 Impact factor: 19.112